NBIX Neurocrine Biosciences, Inc.
Healthcare$156.70+0.77%ClosedMarket Cap: $15.76B
As of 2026-05-25
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
 VIRS | 28,135 | 4.13% | |
 TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 28,135 | 4.13% |
 LSLT | Pacer Salt Low truBeta US Market ETF | 28,135 | 4.13% |
 SLT | Pacer Salt High truBeta US Market ETF | 28,135 | 4.13% |
 VETS | 28,135 | 4.13% | |
 PBE | Invesco Biotechnology & Genome ETF | 53,660 | 2.89% |
 DEF | Invesco Defensive Equity ETF | 30,107 | 2.19% |
 POWA | Invesco Bloomberg Pricing Power ETF | 30,107 | 2.19% |
 BBH | VanEck Biotech ETF | 54,628 | 1.97% |
 BUL | Pacer US Cash Cows Growth ETF | 15,676 | 1.66% |
 AFTY | Pacer CSOP FTSE China A50 ETF | 30,314 | 1.44% |
 VFLO | 607,961 | 1.30% | |
 XBI | 654,044 | 1.22% | |
 IBB | iShares Biotechnology ETF | 727,502 | 1.20% |
 RFG | Invesco S&P MidCap 400 Pure Growth ETF | 26,582 | 1.17% |
 SILX | ETFMG Prime 2x Daily Junior Silver Miners ETF | 13,381 | 1.11% |
 LABU | Direxion Daily S&P Biotech Bull 3X ETF | 32,760 | 0.87% |
 MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 152,785 | 0.82% |
 NNK | 610,411 | 0.82% | |
 IJK | iShares S&P Mid-Cap 400 Growth ETF | 610,411 | 0.82% |